SEARCH VEGSOURCE:

 

 

Follow Ups | Post Followup | Back to Discussion Board | VegSource
See spam or
inappropriate posts?
Please let us know.
  




From: TSS (216-119-144-35.ipset24.wt.net)
Subject: Blood alert: thousands may be infected with vCJD
Date: August 28, 2004 at 7:12 pm PST

-------- Original Message --------
Subject: Blood alert: thousands may be infected with vCJD
Date: Sat, 28 Aug 2004 19:17:13 -0500
From: "Terry S. Singeltary Sr."
Reply-To: Bovine Spongiform Encephalopathy
To: BSE-L@UNI-KARLSRUHE.DE


######## Bovine Spongiform Encephalopathy #########

Blood alert: thousands may be infected with vCJD

By Liam McDougall ,
Health Correspondent


THOUSANDS of people who received blood products prior to 1999 are to be
warned they may be incubating variant Creutzfeldt-Jakob Disease (vCJD),
the human form of mad cow disease.

Health chiefs are to take the unprecedented step of writing to all those
patients who received the blood from donors who subsequently died from
the brain-wasting disease.

The move, ordered by the department of health in England, is the
strongest sign yet that ministers are preparing for a new epidemic of
the disease spread through blood.

Until now, they have always maintained that infection through a
transfusion is a theoretical risk.

The letters are to be sent out to patients, including hundreds of Scots,
at the end of September after the Health Protection Agency carried out a
risk assessment on UK patients who received blood or plasma products,
prior to all plasma being sourced from the US in 1999.

It is understood the letters will urge each patient to contact a
specialist. The vCJD risk assessment, first announced by Westminster
Health Secretary John Reid in December last year, was ordered at the
time as a precautionary measure after a patient who had received a trans
fusion from someone with vCJD also died of the disease.

Although the donor showed no signs of the condition when they gave blood
in 1996, they developed the disease in 1999 and subsequently died from
vCJD. The recipient of the blood died in the autumn of 2003 and at a
post-mortem vCJD was found in their brain.

On December 17 last year Reid told the Commons that the case was not a
proven causal connection but that the possibility of this being
transfusion-related cannot be discounted. It was the first report in
the world to warn of the possible transmission of vCJD from person to
person via blood.

In March he banned blood donations from anyone who had received a
transfusion since 1980 to prevent vCJD being spread.

The department of health last night refused to reveal the outcome of the
risk assessment, but it is understood that behind-the-scenes talks have
been ongoing with senior health officials and groups such as the
Haemophilia Society about the potential outcome of the exercise.

Other categories of patients, such as those with leukaemia, burns
victims and pregnant women, can all be treated with blood products. But
those most exposed are likely to be haemophilacs who use the products to
help their blood to clot.

The latest figures from the National CJD Surveillance Unit in Edinburgh
show the number of deaths in the UK definitely or probably caused by
vCJD now stands at 147. However, news of the department of health move
has fuelled fears of a new epidemic of vCJD, the human form of BSE, from
blood.

Bruce Norval, a haemophiliac from Fortrose, near Inverness, said: Its
very possible that we will have a secondary epidemic via blood from the
initial victims who contracted vCJD by eating infected beef.

Scientists have estimated that almost 4000 people could be harbouring
vCJD, based on studies of appendix samples.

A Department of Health spokeswoman said: We have asked the HPA to lead
on preparations for notifying patients who have received plasma
products, and we have been working with the agency, clinicians
representatives and patient groups.

People who may be concerned should contact NHS Direct on 0845 4647

29 August 2004

http://www.sundayherald.com/44447

> prior to all plasma being sourced from the US in 1999.


I would not count on that being much safer considering
the lack of surveillance of all human/animal TSEs in the
USA, Scrapie in the USA for decades, CWD spreading,
and the very young victims of CJD in the USA. Has anyone
read the blood violation warning letters lately?

http://neuro-mancer.mgh.harvard.edu/ubb/Forum24/HTML/000236.html

http://www.prwatch.org/forum/showthread.php?p=6881

http://disc.server.com/discussion.cgi?disc=167318;article=1064;title=CJD%20WATCH

-------- Original Message --------
Subject: Blood products, collected from donors whose medical history
screening regarding risk factors for variant Creutzfeldt-Jacob disease
(vCJD) RECALL UPDATE
Date: Sun, 18 Jul 2004 15:36:11 -0500
From: "Terry S. Singeltary Sr."
Reply-To: Bovine Spongiform Encephalopathy
To: BSE-L@uni-karlsruhe.de


######## Bovine Spongiform Encephalopathy #########

JUNE/JULY 2004 BLOOD RECALL UPDATE vCJD ONLY

PRODUCT
a) Red Blood Cells, Leukocytes Reduced.
Recall # B-1630-4;
b) Red Blood Cells, Leukocytes Reduced, Irradiated.
Recall # B-1631-4;
c) Platelets Pheresis, Leukocytes Reduced.
Recall # B-1632-4;
d) Platelets Pheresis, Leukocytes Reduced, Irradiated.
Recall # B-1633-4;
e) Fresh Frozen Plasma. Recall # B-1634-4;
f) Plasma, Frozen. Recall # B-1635-4;
g) Red Blood Cells, For Manufacturing Use Only.
Recall # B-1636-4;
h) Recovered Plasma. Recall # B-1637-4.
CODE
a) Unit numbers: 40FF51296, 40FF51405, 40FF51479,
40FF51604, 40FF51657, 40FF51800, 40FF51838, 40FF51877,
40FF51968, 40FF51998, 40FF52129, 40FF52254, 40FF52264,
40FF52289, 40FF52457, 40FF52659, 40FF52674, 40FF52766,
40FF52771, 40FF53014, 40FF53115, 40FF53274, 40FF53342,
40FF53648, 40FF53690, 40FF53731, 40FF53757, 40FF53955,
40FF54040, 40FF54053, 40FF54211, 40FF54214, 40FF54346,
40FF54350, 40FF54372, 40FF54381, 40FF54440, 40FF54576,
40FF55054, 40FF55105, 40FF55120, 40FF55131, 40FF55190,
40FF55492; 40FQ31137, 40FQ31160, 40FQ31258, 40FQ31317,
40FQ31357, 40FQ31366, 40FQ31489, 40FQ31564, 40FQ31575,
40FQ31594, 40FQ31642, 40FQ31686, 40FQ31753, 40FQ31772,
40FQ31817, 40FQ31853, 40FQ31926, 40FQ31970, 40FQ32061,
40FQ32085, 40FQ32195, 40FQ32253, 40FQ32279, 40FQ32337,
40FQ32341, 40FQ32363, 40FQ32430, 40FQ32460, 40FQ32526,
40FQ32555, 40FQ32606, 40FQ32721, 40FQ32736, 40FQ32753,
40FQ32768, 40FQ32843, 40FQ33067, 40FQ33152, 40FQ33183,
40FQ33427, 40FQ33609, 40FQ33658, 40FQ33673, 40FQ33787,
40FQ33798, 40FQ33973;
b) Unit numbers: 40FF51164, 40FQ31378, 40FQ31694;
c) Unit numbers: 40FP16037-2, 40FP16497-1, 40FP16746-1,
40FP17118-1, 40FP17118-2, 40FP18019-1, 40FP18019-2;
d) Unit numbers: 40FP15763-1, 40FP16746-2;
e) Unit numbers: 40FQ31694, 40FQ32061, 40FQ32768,
40FQ33658, 40FQ33673, 40FQ33787;
f) Unit numbers: 40FF52129, 40FF54440, 40FF55105,
40FF55120, 40FQ32279, 40FQ32341;
g) Unit number: 40FQ32200;
h) Unit numbers: 40FF51164, 40FF51174, 40FF51296,
40FF51405, 40FF51479, 40FF51604, 40FF51657, 40FF51800,
40FF51838, 40FF51877, 40FF51968, 40FF51998, 40FF52254,
40FF52264, 40FF52289, 40FF52457, 40FF52655, 40FF52659,
40FF52674, 40FF52766, 40FF52771, 40FF53014, 40FF53115,
40FF53274, 40FF53342, 40FF53648, 40FF53690, 40FF53731,
40FF53757, 40FF53955, 40FF54040, 40FF54053, 40FF54211,
40FF54214, 40FF54346, 40FF54350, 40FF54372, 40FF54381,
40FF54576, 40FF55054, 40FF55131, 40FF55190, 40FF55492,
40FQ31137, 40FQ31160, 40FQ31258, 40FQ31317, 40FQ31357,
40FQ31366, 40FQ31378, 40FQ31489, 40FQ31564, 40FQ31575,
40FQ31594, 40FQ31642, 40FQ31686, 40FQ31753, 40FQ31772,
40FQ31817, 40FQ31853, 40FQ31926, 40FQ31970, 40FQ32085,
40FQ32195, 40FQ32200, 40FQ32253, 40FQ32337, 40FQ32363,
40FQ32430, 40FQ32460, 40FQ32526, 40FQ32555, 40FQ32606,
40FQ32721, 40FQ32736, 40FQ32753, 40FQ32843, 40FQ33067,
40FQ33152, 40FQ33183, 40FQ33427, 40FQ33609, 40FQ33973,
40FQ33798.
RECALLING FIRM/MANUFACTURER
American National Red Cross, Heart of America, Peoria, IL, by telephone
on March 23-24, 2004 and by letter dated March 31, 2004. Firm initiated
recall is complete.
REASON
Blood products, collected from donors whose medical history screening
regarding risk factors for variant Creutzfeldt-Jacob disease (vCJD) was
incomplete, were distributed.
VOLUME OF PRODUCT IN COMMERCE
199 units.
DISTRIBUTION
Nationwide and Switzerland.

http://www.fda.gov/bbs/topics/enforce/2004/ENF00856.html

_______________________________
PRODUCT
Recovered Plasma. Recall # B-1555-4.
CODE
Unit number 49GR60806.
RECALLING FIRM/MANUFACTURER
The American National Red Cross, Southwest Region, Tulsa, OK, by letters
on July 1, 2002, August 20, 2002, and September 6, 2002. Firm initiated
recall is complete.
REASON
Blood product collected from an unsuitable donor due to a history of
travel to an area considered at increased risk of exposure to new
variant Creutzfeldt-Jakob Disease.
VOLUME OF PRODUCT IN COMMERCE
1 unit.
DISTRIBUTION
Switzerland.

_______________________________

http://www.fda.gov/bbs/topics/enforce/2004/ENF00855.html

PRODUCT
Source Plasma. Recall # B-1539-4.
CODE
Unit numbers: ST323408, ST323790, ST324131, and ST324474.
RECALLING FIRM/MANUFACTURER
Biolife Plasma Services L.P., San Antonio, TX, by facsimile on June 26,
2003. Firm initiated recall is complete.
REASON
Blood products were not properly quarantined after the donor disclosed a
history of travel to an area considered at increased risk of exposure to
new variant Creutzfeldt-Jakob Disease (nvCJD).
VOLUME OF PRODUCT IN COMMERCE
4 units.
DISTRIBUTION
NC. _______________________________

PRODUCT
a) Red Blood Cells, Leukocytes Reduced. Recall # B-1543-4;
b) Recovered Plasma. Recall # B-1544-4.
CODE
a) and b) Unit number LS86931.
RECALLING FIRM/MANUFACTURER
The Blood Center of Southeast Wisconsin, Inc., Milwaukee, WI, by
facsimile on November 29,2002, by telephone on December 18, 2002, and
letter on December 24, 2002. Firm initiated recall is complete.
REASON
Blood products collected from an ineligible donor based on the
disclosure of a family member diagnosed with Creutzfeldt-Jakob Disease
(CJD).
VOLUME OF PRODUCT IN COMMERCE
2 units.
DISTRIBUTION
WI and Switzerland. _______________________________

http://www.fda.gov/bbs/topics/enforce/2004/ENF00854.html

PRODUCT
a) Red Blood Cells, Leukocytes Reduced. Recall # B-1493-4;
b) Recovered Plasma. Recall # B-1494-4.
CODE
a) and b) Unit number: 02FE08982.
RECALLING FIRM/MANUFACTURER
American Red Cross, Central Plains Region, Wichita, KS, by telephone on
September 4, 2002, by facsimile on September 9, 2002, and by letter,
dated September 10, 2003. Firm initiated recall is complete.
REASON
Blood products, collected from an unsuitable donor based on a history of
residing in an area considered at increased risk of exposure to variant
Creutzfeldt-Jakob Disease (vCJD), were distributed.
VOLUME OF PRODUCT IN COMMERCE
2 units.
DISTRIBUTION
KS and CA. _______________________________

PRODUCT
Recovered Plasma. Recall # B-1501-4.
CODE
Unit 11GN56565.
RECALLING FIRM/MANUFACTURER
American National Red Cross, Missouri-Illinois Region, St. Louis, MO, by
facsimile on May 29, 2003. Firm initiated recall is complete.
REASON
Blood product, collected from an unsuitable donor due to a history of
travel to an area considered at increased risk of exposure to new
variant Creutzfeldt-Jakob Disease (nvCJD), was distributed.
VOLUME OF PRODUCT IN COMMERCE
1 unit.
DISTRIBUTION
Switzerland. _______________________________

http://www.fda.gov/bbs/topics/enforce/2004/ENF00853.html

PRODUCT
Recovered Plasma. Recall # B-0780-4.
CODE
Unit number 9030179.
RECALLING FIRM/MANUFACTURER
Community Blood Center, Dayton, OH, by facsimile on March 31, 2004. Firm
initiated recall is complete.
REASON
Blood product, collected from an unsuitable donor due to a history of
residing in an area considered at increased risk of exposure to new
variant Creutzfeldt-Jakob Disease (nvCJD), was distributed.
VOLUME OF PRODUCT IN COMMERCE
1 unit.
DISTRIBUTION
Austria.

http://www.fda.gov/bbs/topics/enforce/2004/ENF00852.html

PRODUCT
Source Plasma. Recall # B-1357-4.
CODE
Unit numbers: 0069302, 0069478, 0069923, 0070090, 0075043, 0075384, and
0078620.
RECALLING FIRM/MANUFACTURER
DCI Biologicals Wichita Falls, LLC, Wichita Falls, TX, by facsimile on
August 28, 2002. Firm initiated recall is complete.
REASON
Blood products, collected from a donor who was at increased risk for
variant Creutzfeldt Jakob Disease (vCJD), were distributed.
VOLUME OF PRODUCT IN COMMERCE
7 units.
DISTRIBUTION
KY.

PRODUCT
Source Plasma. Recall # B-1380-4.
CODE
Unit numbers 02DOHA1853, 02DOHA2202, 02DOHA2830, 02DOHA3192, and 02DOHA3534.
RECALLING FIRM/MANUFACTURER
BioLife Plasma Services L.P., Dayton, OH, by facsimile on June 5, and
13, 2003. Firm initiated recall is complete.
REASON
Blood products collected from an unsuitable donor due to a history of
travel to an area considered at increased risk of exposure to new
variant Creutzfeldt-Jakob Disease (nvCJD).
VOLUME OF PRODUCT IN COMMERCE
5 units.
DISTRIBUTION
CA. _______________________________

http://www.fda.gov/bbs/topics/enforce/2004/ENF00850.html

-------- Original Message --------
Subject: [BLOODCJD] BLOOD RECALL CJD/TISSUE JULY 23 -- AUGUST20 2003
Date: Wed, 20 Aug 2003 16:53:41 -0500
From: "Terry S. Singeltary Sr."
Reply-To: bloodcjd@yahoogroups.com
To: BSE-L
CC: cjdvoice , bloodcjd@yahoogroups.com


July 23, 2003

PRODUCT
Human Tissue for Transplantation, Pulmonic Valve. Recall # B-1373-3.
CODE
Unit number 2502656.
RECALLING FIRM/MANUFACTURER
Alabama Tissue Center, Inc., Birmingham, AL, by telephone on May 7,
2003. Firm initiated recall is complete.
REASON
Human tissue was procured from an unsuitable donor due to a possible
familial history of Creutzfeldt-Jakob Disease (nvCJD).
VOLUME OF PRODUCT IN COMMERCE
1 tissue.
DISTRIBUTION
MI.

_______________________________
PRODUCT
a) Red Blood Cells, Leukocytes Reduced. Recall # B-1389-3;
b) Recovered Plasma. Recall # B-1390-3.
CODE
a) and b) Unit numbers 27GG17859 and 27GG16746.
RECALLING FIRM/MANUFACTURER
The American National Red Cross, Greater Alleghenies Region, Johnstown,
PA, by letter and facsimile on December 18, 2002. Firm initiated recall
is complete.
REASON
Blood products collected from an unsuitable donor due to a history of
travel to an area considered at increased risk of exposure to new
variant Creutzfeldt-Jakob Disease (nvCJD).
VOLUME OF PRODUCT IN COMMERCE
4 units.
DISTRIBUTION
PA, and CA.

_______________________________
PRODUCT
Platelets for Further Manufacture. Recall # B-1359-3.
CODE
Unit number 2356275.
RECALLING FIRM/MANUFACTURER
South Texas Blood and Tissue Center, San Antonio, TX, by facsimile on
November 5 and 19, 2002. Firm initiated recall is complete.
REASON
Blood products collected from an unsuitable donor due to a history of
residing in an area considered at increased risk of exposure to new
variant Creutzfeldt-Jakob Disease (nvCJD).
VOLUME OF PRODUCT IN COMMERCE
1 unit.
DISTRIBUTION
TX, and WI.

_______________________________
PRODUCT
a) Red Blood Cells, Leukocytes Reduced. Recall # B-1357-3;
b) Fresh Frozen Plasma. Recall # B-1358-3.
CODE
a) and b) Unit number 2356275.
RECALLING FIRM/MANUFACTURER
South Texas Blood and Tissue Center, San Antonio, TX, by facsimile on
November 5 and 19, 2002. Firm initiated recall is complete.
REASON
Blood products collected from an unsuitable donor due to a history of
residing in an area considered at increased risk of exposure to new
variant Creutzfeldt-Jakob Disease (nvCJD).
VOLUME OF PRODUCT IN COMMERCE
2 units.
DISTRIBUTION
TX, and WI.

_______________________________
PRODUCT
a) Red Blood Cells, Leukocytes Reduced. Recall # B-1360-3;
b) Cryoprecipitated AHF, Pooled. Recall # B-1361-3;
c) Plasma, Cryoprecipitate Reduced. Recall # B-1362-3.
CODE
a) and c) Unit number 2348972;
b) Unit number 4018697.
RECALLING FIRM/MANUFACTURER
South Texas Blood and Tissue Center, San Antonio, TX, by facsimile on
December 24, 2002, and February 18, 2003. Firm initiated recall is complete.
REASON
Blood products collected from an unsuitable donor due to a history of
residing in an area considered at increased risk of exposure to new
variant Creutzfeldt-Jakob Disease (nvCJD).
VOLUME OF PRODUCT IN COMMERCE
2 units; 1 pool.
DISTRIBUTION
TX.

_______________________________

http://www.fda.gov/bbs/topics/enforce/2003/ENF00805.html
=================================================

August 6, 2003

______________________________
PRODUCT
a) Fresh Frozen Plasma. Recall # B-1374-3;
b) Cryoprecipitate. Recall # B-1375-3;
c) Recovered Plasma. Recall # B-1376-3.
CODE
a) Unit LE14726;
b), and c) Unit FG67643.
RECALLING FIRM/MANUFACTURER
Healthcare Provider Services, Inc., dba Rhode Island Blood Center,
Providence, RI, by letter or fax dated March 13, 2003. Firm initiated
recall is complete.
REASON
Blood products, collected from a donor who was at increased risk for new
variant Creutzfeldt Jakob Disease (nvCJD), were distributed.
VOLUME OF PRODUCT IN COMMERCE
3 units.
DISTRIBUTION
ME, and Switzerland.

______________________________

PRODUCT
a) Red Blood Cells, Leukoreduced. Recall # B-1377-3;
b) Platelets. Recall # B-1378-3;
c) Fresh Froxen Plasma. Recall # B-1379-3.
CODE
a), b), and c) Unit LE06855.
RECALLING FIRM/MANUFACTURER
Healthcare Provider Services, Inc., dba Rhode Island Blood Center,
Providence, RI, by telephone on February 25, 2003. Firm initiated recall
is complete.
REASON
Blood products, collected from a donor who was at increased risk for new
variant Creutzfeldt Jakob Disease (nvCJD), were distributed.
VOLUME OF PRODUCT IN COMMERCE
3 units.
DISTRIBUTION
RI.
______________________________

PRODUCT
Recovered Plasma. Recall # B-1419-3.
CODE
Unit number 21KC43309.
RECALLING FIRM/MANUFACTURER
The American National Red Cross, Pacific Northwest Region, Portland, OR,
by electronic mail on June 11, 2002. Firm initiated recall is complete.
REASON
Blood product collected from an unsuitable donor due to a history of
travel to an area considered at increased risk of exposure to new
variant Creutzfeldt-Jakob Disease (nvCJD).
VOLUME OF PRODUCT IN COMMERCE
1 unit.
DISTRIBUTION
CA.
______________________________

PRODUCT
a) Red Blood Cells, Leukocytes Reduced. Recall # B-1425-3;
b) Cryoprecipitated AHF. Recall # B-1426-3;
c) Recovered Plasma. Recall # B-1427-3.
CODE
a), b), and c) Unit number 30GL32538.
RECALLING FIRM/MANUFACTURER
The American National Red Cross, Northeastern Pennsylvania Region,
Ashley, PA, by telephone on February 17, 2003, by facsimile on February
18, 2003, and by letter on February 20, 2003. Firm initiated recall is
complete.
REASON
Blood product collected from an unsuitable donor due to a history of
travel to an area considered at increased risk of exposure to new
variant Creutzfeldt-Jakob Disease (nvCJD).
VOLUME OF PRODUCT IN COMMERCE
3 units.
DISTRIBUTION
MA, PA, and Switzerland.
______________________________

PRODUCT
Recovered Plasma. Recall # B-1428-3.
CODE
Unit number 9035050.
RECALLING FIRM/MANUFACTURER
East Jefferson General Hospital Blood Bank, Metairie, LA, by letter on
June 29, 2001. Firm initiated recall is complete.
REASON
Blood product collected from an unsuitable donor due to a history of
residing in an area considered at risk of exposure to new variant
Creutzfeldt-Jakob Disease (nvCJD).
VOLUME OF PRODUCT IN COMMERCE
1 unit.
DISTRIBUTION
FL.
____________________________________

http://www.fda.gov/bbs/topics/enforce/2003/ENF00807.html
============================================
August 13, 2003

_______________________________
PRODUCT
Fresh Frozen Plasma. Recall # B-0860-3.
CODE
Unit 210005.
RECALLING FIRM/MANUFACTURER
Aultman Hospital Association Blood Center, Canton, OH, by letter dated
May 6, 2003. Firm initiated recall is complete.
REASON
Blood product, collected from a donor who was at increased risk for new
variant Creutzfeldt Jakob Disease (nvCJD), was distributed.
VOLUME OF PRODUCT IN COMMERCE
1 unit.
DISTRIBUTION
OH
___________________________________________

http://www.fda.gov/bbs/topics/enforce/2003/ENF00808.html

===============================================
August 20, 2003

______________________________
PRODUCT
Source Plasma. Recall # B-1500-3.
CODE
Unit numbers GP65657, GP65318, GP65152, GP64664, GP64347, GP64201,
GP63700, GP63345, GP63191, GP62863, GP62728, GP62446, GP62305, GP61885,
GP61718, GP61377, GP61226 and GP60291.
RECALLING FIRM/MANUFACTURER
Bio-Blood Components, Inc., Gary, IN, by facsimile on December 16, 2002.
Firm initiated recall is complete.
REASON
Blood products, collected from an unsuitable donor due to a history of
residing in an area considered at increased risk of exposure to new
variant Creutzfeldt-Jakob Disease (nvCJD).
VOLUME OF PRODUCT IN COMMERCE
18 units.
DISTRIBUTION
Germany.
___________________________________________________

http://www.fda.gov/bbs/topics/enforce/2003/ENF00809.html

===============================================


MISSING the bigger picture

http://www.vegsource.com/talk/madcow/messages/92912.html


TSS

######### http://mailhost-alt.rz.uni-karlsruhe.de/warc/bse-l.html ##########





Follow Ups:



Post a Followup

Name:
E-mail: (optional)
Subject:

Comments:

Optional Link URL:
Link Title:
Optional Image URL: